AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
10.02
+0.13 (1.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed
AVITA Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AVITA Medical stock have an average target of 17.25, with a low estimate of 12 and a high estimate of 22. The average target predicts an increase of 72.16% from the current stock price of 10.02.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVITA Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +119.56% | Apr 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +119.56% | Apr 4, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +119.56% | Mar 18, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +119.56% | Feb 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +149.50% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
104.30M
from 64.25M
Increased by 62.33%
Revenue Next Year
136.21M
from 104.30M
Increased by 30.59%
EPS This Year
-0.67
from -2.39
EPS Next Year
-0.19
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 110.4M | 162.8M | 312.9M | ||
| Avg | 104.3M | 136.2M | 203.7M | ||
| Low | 97.9M | 121.4M | 144.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.7% | 56.0% | 129.7% | ||
| Avg | 62.3% | 30.6% | 49.6% | ||
| Low | 52.4% | 16.4% | 5.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.18 | -0.04 | 5.46 | ||
| Avg | -0.67 | -0.19 | 1.76 | ||
| Low | -0.99 | -0.31 | -0.05 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.